Mice double heterozygous (DH) for deletion of insulin receptor and insulin receptor substrate-1 are lean, insulin resistant, and have a phenotype that strongly depends on the genetic background of the mouse. On the C57BL/6 (B6) background, DH mice develop marked hyperinsulinemia and diabetes, whereas on the 12956 background, DH mice exhibit only mild elevations of insulin and remain free of diabetes. F2 male mice created by an intercross between these two strains exhibit a 60% incidence of diabetes and a bell-shaped distribution of insulin levels as related to glucose, reminiscent of that in humans with type 2 diabetes. These mice also exhibit a wide range of leptin levels as related to body weight. A genome-wide scan of F2 mice reveals a quantitative trait locus (QTL) related to hyperinsulinemia on chromosome 14 (D14Mit55) with a peak logarithm of odds (LOD) score of 5.6, accounting for up to 69% of this trait. A QTL with a LOD score of 3.7 related to hyperleptinemia is present on chromosome 7 at D12Mit38 (a marker previously assigned to chromosome 12) in the area of the uncoupling protein 2/3 gene cluster. This locus also interacts synergistically with D14Mit55 in development of hyperinsulinemia and with a QTL on chromosome 12 (D12Mit231) related to hyper-glycemia. These data demonstrate how multiple genetic modifiers can interact and influence the development of diabetes and the phenotype of animals with genetically programmed insulin resistance and provide evidence as to the location and nature of these genes. Diabetes 52: 1535-1543,2003.
机构:
Beth Israel Deaconess Med Ctr, Harvard Med Sch, Div Endocrinol, Dept Med, Boston, MA 02215 USABeth Israel Deaconess Med Ctr, Harvard Med Sch, Div Endocrinol, Dept Med, Boston, MA 02215 USA
Boss, O
Hagen, T
论文数: 0引用数: 0
h-index: 0
机构:
Beth Israel Deaconess Med Ctr, Harvard Med Sch, Div Endocrinol, Dept Med, Boston, MA 02215 USABeth Israel Deaconess Med Ctr, Harvard Med Sch, Div Endocrinol, Dept Med, Boston, MA 02215 USA
Hagen, T
Lowell, BB
论文数: 0引用数: 0
h-index: 0
机构:
Beth Israel Deaconess Med Ctr, Harvard Med Sch, Div Endocrinol, Dept Med, Boston, MA 02215 USABeth Israel Deaconess Med Ctr, Harvard Med Sch, Div Endocrinol, Dept Med, Boston, MA 02215 USA
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Camps, M
Nichols, A
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Nichols, A
Arkinstall, S
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
机构:
Beth Israel Deaconess Med Ctr, Harvard Med Sch, Div Endocrinol, Dept Med, Boston, MA 02215 USABeth Israel Deaconess Med Ctr, Harvard Med Sch, Div Endocrinol, Dept Med, Boston, MA 02215 USA
Boss, O
Hagen, T
论文数: 0引用数: 0
h-index: 0
机构:
Beth Israel Deaconess Med Ctr, Harvard Med Sch, Div Endocrinol, Dept Med, Boston, MA 02215 USABeth Israel Deaconess Med Ctr, Harvard Med Sch, Div Endocrinol, Dept Med, Boston, MA 02215 USA
Hagen, T
Lowell, BB
论文数: 0引用数: 0
h-index: 0
机构:
Beth Israel Deaconess Med Ctr, Harvard Med Sch, Div Endocrinol, Dept Med, Boston, MA 02215 USABeth Israel Deaconess Med Ctr, Harvard Med Sch, Div Endocrinol, Dept Med, Boston, MA 02215 USA
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Camps, M
Nichols, A
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Nichols, A
Arkinstall, S
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland